Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients

Covid19 Clinical Trial

— IRCIP  

Official title:

Institutional COVID-19 Patient Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04839107
• Other study ID #: 5604
• Status: Recruiting
• Start date: April 14, 2020
• Est. completion date: December 31, 2021

Study information

• Verified date: April 2021
• Source: Hospital Italiano de Buenos Aires
• Contact: Veronica A Peuchot, MD
• Phone: 4959 0200
• Email: veronica.peuchot[@]hospitalitaliano.org.ar
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Creation of an Institutional Registry system for patients with confirmed COVID-19 infection with the collection of epidemiological data, risk factors, diagnosis, prognoses, treatment, follow-up and survival.

Description:

Ambispective observational cohort with administrative admission date corresponding to the day of positivity of the PCR test for COVID-19, and discharge date of the cohort to the date corresponding to the epidemiological discharge, last contact with the health system and / or date of death. Due to its institutional nature, the registry will collect data from the different patients who are assisted at different levels of the institution: emergency department, hospitalization in the general ward, critical areas, outpatient monitoring (including telemedicine) and home hospitalization.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20000
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Patient assisted by HIBA adult services
• Patient diagnosed with COVID-19

Related Conditions & MeSH terms

• Covid19

Locations

Country	Name	City	State
Argentina	Hospital Italiano	Caba	Ciudad Autónoma De Buenos Aires

Sponsors (1)

Lead Sponsor	Collaborator
Hospital Italiano de Buenos Aires

Country where clinical trial is conducted

Argentina, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality rate	Proportion of deceased persons from PCR positivity to epidemiological status out of the total number of infected persons followed in the same period	From the date of the positivization of the PCR to the date of death or epidemiological discharge, whichever occurs first, assessed up to 30 days.
Primary	Readmission rate	Requirements for re-admission during the post-discharge period for a COVID hospitalization	Within a month of discharge